Somatic hypermutation and mRNA expression levels of the BCL-6 gene in patients with hepatitis C virus-associated lymphoproliferative diseases

Journal of Viral Hepatitis

Volumn 14, Issue 7, 2007, Pages 484-491

  Hofmann, W P ^a   Fernandez, B ^a   Herrmann, E ^a   Welsch, C ^a,b   Mihm, U ^a   Kronenberger, B ^a   Feldmann, G ^c   Spengler, U ^c   Zeuzem, S ^a   Sarrazin, C ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b MAX PLANCK INSTITUTE FOR INFORMATICS   (Germany)

^c UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

B cell lymphoma; Cryoglobulinaemia; Genetic complexity; Genetic diversity; Peripheral blood mononuclear cells

Indexed keywords

MESSENGER RNA; PROTEIN BCL 6;

ARTICLE; B CELL LYMPHOMA; CHRONIC HEPATITIS; CONTROLLED STUDY; CRYOGLOBULINEMIA; GENE EXPRESSION REGULATION; GENE FREQUENCY; GENE SEQUENCE; GENETIC VARIABILITY; HEPATITIS B; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; IN VITRO STUDY; MOLECULAR CLONING; MUTATIONAL ANALYSIS; NONHODGKIN LYMPHOMA; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SOMATIC MUTATION; TREATMENT RESPONSE; VIRUS CARCINOGENESIS;

BASE SEQUENCE; CONSENSUS SEQUENCE; CRYOGLOBULINEMIA; DNA-BINDING PROTEINS; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; LEUKOCYTES, MONONUCLEAR; LYMPHOMA, B-CELL; LYMPHOPROLIFERATIVE DISORDERS; MOLECULAR SEQUENCE DATA; MUTATION; RNA, MESSENGER;

EID: 34250647505     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/j.1365-2893.2006.00833.x     Document Type: Article

References (34)

1. Agnello V, Chung RT, Kaplan LM. A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med 1992 327 : 1490 1495.
2. De RV, De Vita S, Marzotto A et al. Pre-malignant and malignant lymphoproliferations in an HCV-infected type II mixed cryoglobulinemic patient are sequential phases of an antigen-driven pathological process. Int J Cancer 2000 87 : 211 216.
3. Zuckerman E, Zuckerman T. Hepatitis C and B-cell lymphoma: the hemato-hepatologist linkage. Blood Rev 2002 16 : 119 125.
4. Chan CH, Hadlock KG, Foung SK, Levy S. V(H)1-69 gene is preferentially used by hepatitis C virus-associated B cell lymphomas and by normal B cells responding to the E2 viral antigen. Blood 2001 97 : 1023 1026.
5. Gisbert JP, Garcia-Buey L, Pajares JM, Moreno-Otero R. Prevalence of hepatitis C virus infection in B-cell non-Hodgkin's lymphoma: systematic review and meta-analysis. Gastroenterology 2003 125 : 1723 1732.
6. Hermine O, Lefrere F, Bronowicki JP et al. Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection. N Engl J Med 2002 347 : 89 94.
7. Cacoub P, Ratziu V, Myers RP et al. Impact of treatment on extra hepatic manifestations in patients with chronic hepatitis C. J Hepatol 2002 36 : 812 818.
8. Quinn ER, Chan CH, Hadlock KG, Foung SK, Flint M, Levy S. The B-cell receptor of a hepatitis C virus (HCV)-associated non-Hodgkin lymphoma binds the viral E2 envelope protein, implicating HCV in lymphomagenesis. Blood 2001 98 : 3745 3749.
9. Cocquerel L, Kuo CC, Dubuisson J, Levy S. CD81-dependent binding of hepatitis C virus E1E2 heterodimers. J Virol 2003 77 : 10677 10683.
10. Hofmann WP, Herrmann E, Kronenberger B et al. Association of HCV-related mixed cryoglobulinemia with specific mutational pattern of the HCV E2 protein and CD81 expression on peripheral B lymphocytes. Blood 2004 104 : 1228 1229.
11. Machida K, Cheng KT, Sung VM et al. Hepatitis C virus induces a mutator phenotype: enhanced mutations of immunoglobulin and protooncogenes. Proc Natl Acad Sci U S A 2004 101 : 4262 4267.
12. Shaffer AL, Yu X, He Y, Boldrick J, Chan EP, Staudt LM. BCL-6 represses genes that function in lymphocyte differentiation, inflammation, and cell cycle control. Immunity 2000 13 : 199 212.
13. Sanchez-Beato M, Sanchez-Aguilera A, Piris MA. Cell cycle deregulation in B-cell lymphomas. Blood 2003 101 : 1220 1235.
14. Kikuchi M, Miki T, Kumagai T et al. Identification of negative regulatory regions within the first exon and intron of the BCL6 gene. Oncogene 2000 19 : 4941 4945.
15. Wang X, Li Z, Naganuma A, Ye BH. Negative autoregulation of BCL-6 is bypassed by genetic alterations in diffuse large B cell lymphomas. Proc Natl Acad Sci U S A 2002 99 : 15018 15023.
16. Pasqualucci L, Migliazza A, Basso K, Houldsworth J, Chaganti RS, Dalla-Favera R. Mutations of the BCL6 proto-oncogene disrupt its negative autoregulation in diffuse large B-cell lymphoma. Blood 2003 101 : 2914 2923.
17. Ye BH, Lista F, Lo CF et al. Alterations of a zinc finger-encoding gene, BCL-6, in diffuse large-cell lymphoma. Science 1993 262 : 747 750.
18. Dalla-Favera R, Migliazza A, Chang CC et al. Molecular pathogenesis of B cell malignancy: the role of BCL-6. Mechanisms of B Cell Neoplasia 1998 1999 246 : 257 265.
19. Pasqualucci L, Migliazza A, Fracchiolla N et al. BCL-6 mutations in normal germinal center B cells: evidence of somatic hypermutation acting outside Ig loci. Proc Natl Acad Sci U S A 1998 95 : 11816 11821.
20. Shen HM, Peters A, Baron B, Zhu X, Storb U. Mutation of BCL-6 gene in normal B cells by the process of somatic hypermutation of Ig genes. Science 1998 280 : 1750 1752.
21. Migliazza A, Martinotti S, Chen W et al. Frequent somatic hypermutation of the 5′ noncoding region of the BCL6 gene in B-cell lymphoma. Proc Natl Acad Sci U S A 1995 92 : 12520 12524.
22. Storb U, Shen HM, Michael N, Kim N. Somatic hypermutation of immunoglobulin and non-immunoglobulin genes. Philos Trans R Soc Lond B Biol Sci 2001 356 : 13 19.
23. Lossos IS, Czerwinski DK, Alizadeh AA et al. Prediction of survival in diffuse large-B-cell lymphoma based on the expression of six genes. N Engl J Med 2004 350 : 1828 1837.
24. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001 25 : 402 408.
25. Sarrazin C, Herrmann E, Bruch K, Zeuzem S. Hepatitis C virus nonstructural 5A protein and interferon resistance: a new model for testing the reliability of mutational analyses. J Virol 2002 76 : 11079 11090.
26. Dammacco F, Sansonno D, Piccoli C, Racanelli V, D'Amore FP, Lauletta G. The lymphoid system in hepatitis C virus infection: autoimmunity, mixed cryoglobulinemia, and overt B-cell malignancy. Semin Liver Dis 2000 20 : 143 157.
27. Niu HF. The proto-oncogene BCL-6 in normal and malignant B cell development. Hematol Oncol 2002 20 : 155 166.
28. Zan H, Li Z, Yamaji K, Dramitinos P, Cerutti A, Casali P. B cell receptor engagement and T cell contact induce Bcl-6 somatic hypermutation in human B cells: identity with Ig hypermutation. J Immunol 2000 165 : 830 839.
29. Libra M, Capello D, Gloghini A et al. Analysis of aberrant somatic hypermutation (SHM) in non-Hodgkin's lymphomas of patients with chronic HCV infection. J Pathol 2005 206 : 87 91.
30. Rosa D, Saletti G, De Gregorio E et al. Activation of naive B lymphocytes via CD81, a pathogenetic mechanism for hepatitis C virus-associated B lymphocyte disorders. Proc Natl Acad Sci U S A 2005 102 : 18544 18549.
31. Allman D, Jain A, Dent A et al. BCL-6 expression during B-cell activation. Blood 1996 87 : 5257 5268.
32. Hsieh T, Wu JM. Apoptosis and restriction of G(1)/S cell cycle by fenretinide in Burkitt's lymphoma mutu I cell line accessed with bcl-6 down-regulation. Biochem Biophys Res Commun 2000 276 : 1295 1301.
33. Toubi E, Kessel A, Peri R et al. Enhanced apoptosis of peripheral CD5-negative B lymphocytes from chronically hepatitis C virus-infected patients: reversal after antiviral treatment. J Virol 2004 78 : 11379 11384.
34. Sung VM, Shimodaira S, Doughty AL et al. Establishment of B-cell lymphoma cell lines persistently infected with hepatitis C virus in vivo and in vitro: the apoptotic effects of virus infection. J Virol 2003 77 : 2134 2146.